<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4</volume><submitter>Lefevre L</submitter><pubmed_abstract>Adrenocortical cancer (ACC) is a very aggressive tumor, and genomics studies demonstrate that the most frequent alterations of driver genes in these cancers activate the Wnt/β-catenin signaling pathway. However, the adrenal-specific targets of oncogenic β-catenin-mediating tumorigenesis have not being established. A combined transcriptomic analysis from two series of human tumors and the human ACC cell line H295R harboring a spontaneous β-catenin activating mutation was done to identify the Wnt/β-catenin targets. Seven genes were consistently identified in the three studies. Among these genes, we found that AFF3 mediates the oncogenic effects of β-catenin in ACC. The Wnt response element site located at nucleotide position -1408 of the AFF3 transcriptional start sites (TSS) mediates the re</pubmed_abstract><journal>Oncogenesis</journal><pagination>e161</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4521181</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma.</pubmed_title><pmcid>PMC4521181</pmcid><pubmed_authors>Perlemoine K</pubmed_authors><pubmed_authors>Blugeon C</pubmed_authors><pubmed_authors>Bertherat J</pubmed_authors><pubmed_authors>Lefevre L</pubmed_authors><pubmed_authors>Ragazzon B</pubmed_authors><pubmed_authors>Hantel C</pubmed_authors><pubmed_authors>Beuschlein F</pubmed_authors><pubmed_authors>Drougat L</pubmed_authors><pubmed_authors>Val P</pubmed_authors><pubmed_authors>Rodriguez S</pubmed_authors><pubmed_authors>Giraud M</pubmed_authors><pubmed_authors>Omeiri H</pubmed_authors><pubmed_authors>de Reynies A</pubmed_authors><pubmed_authors>Rizk-Rabin M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma.</name><description>Adrenocortical cancer (ACC) is a very aggressive tumor, and genomics studies demonstrate that the most frequent alterations of driver genes in these cancers activate the Wnt/β-catenin signaling pathway. However, the adrenal-specific targets of oncogenic β-catenin-mediating tumorigenesis have not being established. A combined transcriptomic analysis from two series of human tumors and the human ACC cell line H295R harboring a spontaneous β-catenin activating mutation was done to identify the Wnt/β-catenin targets. Seven genes were consistently identified in the three studies. Among these genes, we found that AFF3 mediates the oncogenic effects of β-catenin in ACC. The Wnt response element site located at nucleotide position -1408 of the AFF3 transcriptional start sites (TSS) mediates the re</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jul</publication><modification>2026-05-30T03:44:05.87Z</modification><creation>2019-03-27T01:56:07Z</creation></dates><accession>S-EPMC4521181</accession><cross_references><pubmed>26214578</pubmed><doi>10.1038/oncsis.2015.20</doi></cross_references></HashMap>